News Focus
News Focus
Followers 5
Posts 118
Boards Moderated 0
Alias Born 07/09/2016

Re: None

Saturday, 12/13/2025 10:16:52 AM

Saturday, December 13, 2025 10:16:52 AM

Post# of 516066
Unless there were changes, here are the CV’s of the two rapporteurs assigned to Anavex’s application to EMA. (I posted these on iHub on November 11 before the negative trend, etc.).

https://www.ema.europa.eu/sites/default/files/ContactsandExperts/experts_files/vrijlandtp_CV_en.pdf

https://www.ema.europa.eu/sites/default/files/ContactsandExperts/experts_files/wangi_CV_en.pdf

Dr. Vrijlandt’s background is in cardiometabolic diseases, diabetes, osteoporosis and diagnostics, and infectious diseases and rare metabolic diseases.

Dr. Wang’s background is in urology with an interest in oncology.

In any event, we had two rapporteurs with no background in CNS diseases leading our efforts.

No surprise that we had the outcome we did this week. I saw somewhere that our new rapporteurs will have more suitable backgrounds. Hopefully we’ll have two individuals who know the difference between UTI's and dementia on this go-around.

Bill
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News